Stevanato Group S.p.A. (STVN)

Stevanato Group supplies glass primary packaging and drug-delivery systems for the pharmaceutical and biotech industries, including vials, syringes and cartridges. It also offers inspection machines, assembly equipment and analytical services that support sterile fill-finish operations. The company is known for high-precision containment solutions used with injectable drugs and biologics, serving global pharma manufacturers and contract fillers.

Market
NYSE
Sector
Healthcare
Trend
Neutral
Last close
19.39 (+3.03% on the day)
MA50
20.8
MA200
18.11
52-week range
13.38–27.51
Market cap
5.2B USD
P/E
33.16
Dividend yield
0%
Data as of
2026-10-22
Quarterly revenue and earnings, millions of EUR
QuarterRevenueYoY %EarningsYoY %
Q2 2025280—29.78.9%
Q3 2025303.2—36.11.7%
Q4 2025346.5—47.5-12.9%
Q1 2026273.6—28-6.7%
Q2 20263027.8%23-22.7%

All markets — KeepWinning global stock screener

Other companies on NYSE: White Mountains Insurance Group, Ltd. (WTM), West Fraser Timber Co. Ltd. (WFG), Kite Realty Group Trust (KRG), Materion Corporation (MTRN), Graham Holdings Company (GHC), Boyd Gaming Corporation (BYD)